NCT01648751 - Vaginal Estrogen and Pelvic Floor Physical Therapy in Women With Symptomatic Mild Prolapse | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

May 31, 2012

Primary Completion Date

March 2, 2023

Study Completion Date

March 2, 2023

Conditions

Pelvic Organ Prolapse

Interventions

DRUG

Vaginal estrogen

1 gram vaginally for 7 days, followed by 1 gram vaginally twice weekly thereafter

DRUG

Placebo

1 gram vaginally for 7 days, followed by 1 gram vaginally twice weekly thereafter

Trial Locations (1)

Magee-Womens Hospital, University of Pittsburgh, Pittsburgh